Funding for this research was provided by:
Received: 31 March 2020
Accepted: 16 May 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: Not applicable.
: All authors gave their informed consent.
: J. Bousquet reports personal fees and other from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach, outside the submitted work. other from Kyomed. Dr. Haahtela reports personal fees from Mundipharma, Novartis, and Orion Pharma, outside the submitted work.